65 results on '"P. Yamdagni"'
Search Results
52. Charged particle correlations in <img src="/fulltext-image.asp?format=htmlnonpaginated&src=K20W41312H781447_html\10052_2005_Article_BF01579906_TeX2GIFIE1.gif" border="0" alt=" $$\bar pp$$ " /> collisions at c.m. energies of 200, 546 and 900 GeV
- Author
-
Ansorge, R. E., Åsman, B., Booth, C. N., Burow, L., Carlson, P., DeWolf, R. S., Eckart, B., Ekspong, G., Fuglesang, C., Gaudaen, J., Geich-Gimbel, C., Holl, B., Hospes, R., Jon-And, K., Johnson, D. P., Lotse, F., Manthos, N., Munday, D. J., Ovens, J. E. V., Pelzer, W., Rushbrooke, J. G., Schmickler, H., Triantis, F., Van Hamme, L., Walck, C., Ward, C. P., Ward, D. R., Webber, C. J. S., White, T. O., Wilquet, G., and Yamdagni, N.
- Abstract
We present data on two-particle pseudorapidity and multiplicity correlations of charged particles for non single-diffractive at c.m. energies of 200, 546 and 900 GeV. Pseudorapidity correlations interpreted in terms of a cluster model, which has been motivated by this and other experiments, require on average about two charged particles per cluster. The decay width of the clusters in pseudorapidity is approximately independent of multiplicity and of c.m. energy. The investigations of correlations in terms of pseudorapidity gaps confirm the picture of cluster production. The strength of forward-backward multiplicity correlations increases linearly with ins and depends strongly on position and size of the pseudorapidity gap separating the forward and backward interval. All our correlation studies can be understood in terms of a cluster model in which clusters contain on average about two charged particles, i.e. are of similar magnitude to earlier estimates from the ISR.
- Published
- 1988
- Full Text
- View/download PDF
53. The Hydrogen Bond Energies in ClHCl−and Cl−(HCl)n
- Author
-
Yamdagni, R. and Kebarle, P.
- Abstract
The equilibrium constants for the gas phase reactions: Cl−(HCl)n = Cl−(HCl)n−1 + HCl, (n, n−1) were measured at different temperatures with a pulsed electron beam high pressure mass spectrometer. This allowed determination of ΔGn,n−10, ΔHn,n−10, and ΔSn,n−10for reactions with n = 1 to n = 4. The enthalpy change for the reaction: (ClHCl)− = Cl− + HCl was ΔH1.00 = 23.7 kcal/mol. This value is much higher than the literature value of 14.2 kcal/mol based on Born cycles. The stabilities of the Cl−(HCl)nclusters are compared with those of OH−(H2O)nand Cl−(H2O)nmeasured earlier. It is found that the (ClHCl)−is nearly as stable as the (HOHOH)−species but that the stabilities of the higher Cl−(HCl)nclusters decreases much more rapidly than that of OH−(H2O)n. The initial strong interaction in (ClHCl) is assumed to be due to the high polarizability of Cl. For large nthis effect becomes unimportant. Cl−HOH is much more weakly bound than (ClHCl)−, however, at high nthe Cl−(H2O)ninteractions become more favorable.
- Published
- 1974
- Full Text
- View/download PDF
54. Synthesis and Contractile Activities of Cyclic Thrombin Receptor-Derived Peptide Analogues with a Phe-Leu-Leu-Arg Motif: Importance of the Phe/Arg Relative Conformation and the Primary Amino Group for Activity
- Author
-
Matsoukas, J. M., Panagiotopoulos, D., Keramida, M., Mavromoustakos, T., Yamdagni, R., Wu, Q., Moore, G. J., Saifeddine, M., and Hollenberg, M. D.
- Abstract
Based on the minimal peptide sequence (Phe-Leu-Leu-Arg) that has been found to exhibit biological activity in a gastric smooth muscle contractile assay for thrombin receptor-activating peptides, the cyclic peptide analogues cyclo(Phe-Leu-Leu-Arg-Acp) (
1 ), cyclo(Phe-Leu-Leu-Arg-εLys) (2 ), and cyclo(Phe-Leu-Leu-Arg-Gly) (3 ) have been synthesized by the solid-phase method using benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluoroborate or 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate as cyclization reagents. The contractile activities of compounds1 −3 have been compared with that of the linear thrombin receptor-activating peptide (TRAP) Ser-Phe-Leu-Leu-Arg-NH2 (compound4 ) using a gastric smooth muscle strip assay. Compound2 , wherein the ε-amino group of lysine was coupled to the α-carboxyl of arginine, exhibited a contractile activity comparable to that of the linear TRAP, compound4 . However compound1 , wherein the aminocaproic linker group yielded a ring size the same as for compound2 but without a primary amino group, exhibited a contractile activity 600−1000-fold lower than compounds2 and4 . Compound3 , which exhibited partial agonist activity, was about 100-fold less potent than either compound2 or4 . NMR spectroscopy of compound2 revealed a proximity of the Phe and Arg side chains, leading to a molecular model generated by distance geometry and molecular dynamics, wherein the Phe and Arg residues are shown in proximity on the same side of the peptide ring. We conclude that the Phe and Arg side chains along with the primary amino group form an active recognition motif that is augmented by the presence of a primary amino group in the cyclic peptide. We suggest that a comparable cyclic conformation may be responsible for the interaction of linear TRAPs with the thrombin receptor.- Published
- 1996
55. Conformational Analysis of the Thrombin Receptor Agonist Peptides SFLLR and SFLLR-NH2by NMR: Evidence for a Cyclic Bioactive Conformation
- Author
-
Matsoukas, John, Hollenberg, Morley D., Mavromoustakos, Thomas, Panagiotopoulos, Dimitris, Alexopoulos, Kostas, Yamdagni, Raguav, Wu, Qiao, and Moore, Graham J.
- Abstract
The conformational properties of the pentapeptide Ser-Phe-Leu-Leu-Arg (P5), a human thrombin receptor-derived sequence forming part of a tethered ligand which activates the thrombin receptor, and its more active amide derivative Ser-Phe-Leu-Leu-Arg-NH2(P5-NH2), have been studied by proton NMR spectroscopy in dimethylsulfoxide. Measurements of nuclear Overhauser effects, performed using two-dimensional rotating frame nuclear Overhauser (ROESY) and one-dimensional nuclear Overhauser enhancement (NOE) spectroscopy, revealed that P5 exists mainly in an extended conformation. However, proton–proton 1D-NOEs between Phe CαH and Ser CαH, Leu3CαH and Leu3NH, and Leu4CαH and Leu4NH, as well as between the Ser and Arg sidechains, also implicated a minor conformer for P5 having a curved backbone and a near-cyclic structure. In contrast to P5, measurements of NOEs and ROEs for P5-NH2revealed a more stabilized cyclic structure which may account for its higher biological potency. Thus strong interresidue sequential NH (i)–NH (i+ 1) interactions, as well as C-terminal carboxamide to N-terminal side-chain interactions, i.e., Arg CONH2to Phe ring and Arg CONH2to Ser , observed at lower levels of the ROESY spectrum, supported a curved backbone structure for SFLLR-NH2. Since the higher potaency P5-NH2analogue adopts predominantly a cyclic structure, a cyclic bioactive conformation for thrombin receptor agonist peptides is suggested.
- Published
- 1997
- Full Text
- View/download PDF
56. A bit-serial first-level calorimeter trigger for an LHC detector
- Author
-
Bohm, C., Appelquist, G., Zhao, X., Yamdagni, N., Hellman, S., Johansson, E., and Sellden, B.
- Abstract
A preliminary design of a compact first-level calorimeter trigger, implemented as a farm of local bit-serial systolic arrays, is presented. The bit-serial data representation allows higher processing rates and more compact designs than are possible when using parallel data. More functionality can be incorporated into the Application Specific Integrated Circuits (ASICs) that serve as the main processing elements. The trigger processor seeks local energy clusters, evaluates isolation criteria within the electromagnetic calorimeter and leakage into the hadron calorimeter in order to detect electrons. It uses cluster finding algorithms to identify jets and missing transverse energy to estimate neutrino energies. The processor output serves as decision support for the central first-level trigger and delivers region-of-interest positions to the second-level trigger. In its present form the trigger processor design relies on optical fibers to deliver the input data from the front-end modules and multi-chip modules (MCMs) to harbor the processing ASICs. The fact that the main part of the trigger processor can fit into one or two large crates suggests that the design is not limited by size nor is it strictly limited by cost but can be expanded to accommodate extended algorithms if these are found necessary. Extensive physics simulations will explore these possibilities.<
> - Published
- 1994
- Full Text
- View/download PDF
57. Hydration of CN−, NO2−, NO3−, and OH−in the Gas Phase
- Author
-
Payzant, J. D., Yamdagni, R., and Kebarle, P.
- Abstract
By measuring the A−(H2O)n−1 + H2O = A−(H2O)nequilibria in the gas phase and their temperature dependence, the equilibrium constants and ΔHn, n–1and ΔSn, n–1for some of the hydrates of NO2−, NO3−, CN−, and OH−were determined. Available thermochemical data are used for the evaluation of the total heats of hydration of the above ions. The total heats of hydration were then compared with the ΔH1,0. Relative to the total hydration energies the ΔH1,0of the above ions were found larger than the ΔH1,0of the halide ions.An approximate linear correlation was found to exist between ΔH1,0of negative ions and the heterolytic bond dissociation energy D(A−–H+). With this relationship independent estimates for the electron affinities of NO2and NO3could be obtained.The ΔHn, n–1of OH−were found in essential agreement with earlier measurements from this laboratory and in disagreements with recent measurements (Friedman) which gave much higher values.
- Published
- 1971
- Full Text
- View/download PDF
58. Solvation of Cl−and O2−with H2O, CH3OH, and CH3CN in the gas phase
- Author
-
Yamdagni, R., Payzant, J. D., and Kebarle, P.
- Abstract
Determination of the temperature dependence of the equilibrium constants Kn,n−1for the reactions A −Bn = A −Bn−1 + B where A−equals Cl−and O2−and B is HOH, CH3OH, or CH3CN leads to the corresponding ΔH0n−1, ΔG0n−1,n, and ΔS0n−1,nvalues. The experimental technique is based on mass spectrometric detection of ions escaping from a high pressure ion source. At n = 1, Cl−is solvated most strongly by methanol, then CH3CN and HOH. At higher na cross over is observed with water becoming the best solvent. These results are in agreement with the positive transfer enthalpies and free energies for Cl−from the liquid solvents HOH → CH3OH and HOH → CH3CN reported in the literature.O2−is solvated more strongly than Cl−appearing thus as an ion of "size" intermediate between Cl−and F−Again CH3OH gives the highest interaction for n = 1, however for n > 1 water gives stronger interactions.
- Published
- 1973
- Full Text
- View/download PDF
59. Intrinsic Acidities of α, β, γ Chlorosubstituted Aliphatic Acids from Gas Phase Equilibrian Mesurements
- Author
-
Yamdagni, R. and Kebarle, P.
- Abstract
Measurements of the proton transfer equilibria: A1− + A2H = A2−with a pulsed electron beam high pressure mass spectrometer were extended to α, β, γ chlorosubstituted aliphatic acids. The equilibrium constants were used to evaluate ΔG0for the proton transfer reactions. Assuming ΔG ≈ ΔHand using standard acids AH for which the difference between the bond dissociation energy D(A—H)and the electron affinity of A, EA(A) was known one could evaluate the corresponding difference for the newly measured acids and place them on an absolute acidity scale. The gas phase acidity was observed to increase in the order: acetic, propionic, butyric, γ-Cl butyric, β-Cl butyric, β-Cl propionic, α-Cl butyric, α-Cl propionic, α-Cl acetic. The gas phase acidities are compared with those observed in aqueous solution. The effects of the Cl substituent parallel those in solution but are much larger. The attenuation occurring in solution is attributed to weaker hydrogen bonding of the chloro stabilized acid anions to water molecules.
- Published
- 1974
- Full Text
- View/download PDF
60. ChemInform Abstract: A Chlorinated Monoterpene Ketone (I), Acylated β‐Sitosterol Glycosides (II) and a Flavanone Glycoside (III) from Mentha longifolia (Lamiaceae)
- Author
-
Ali, Muhammad Shaiq, Saleem, Muhammad, Ahmad, Waqar, Parvez, Masood, and Yamdagni, Raghav
- Abstract
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
- Published
- 2002
- Full Text
- View/download PDF
61. ChemInform Abstract: The Thionophosphate—Thiolophosphate Photoisomerization Proceeds Predominantly Through a Non‐chain Radical Pathway. Synthetically Viable Benzylation of Tetrahydrofuran, Propan‐2‐ol and Olefins.
- Author
-
Yadav, Veejendra K., Balamurugan, Rengarajan, Parvez, Masood, and Yamdagni, Raghav
- Abstract
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a “Full Text” option. The original article is trackable via the “References” option.
- Published
- 2001
- Full Text
- View/download PDF
62. Role of different chemicals in mango malformation and related physiological factors
- Author
-
Yamdagni, R., Sandooja, J. K., Madan, R. L., and Mehta, N.
- Published
- 1986
63. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice.
- Author
-
Pang Z, Wu NN, Zhao W, Chain DC, Schaffer E, Zhang X, Yamdagni P, Palejwala VA, Fan C, Favara SG, Dressler HM, Economides KD, Weinstock D, Cavallo JS, Naimi S, Galzin AM, Guillot E, Pruniaux MP, Tocci MJ, and Polites HG
- Subjects
- Adiponectin blood, Adiposity drug effects, Adiposity genetics, Animals, Anti-Obesity Agents therapeutic use, Biomarkers blood, Body Weight genetics, Central Nervous System drug effects, Cholesterol blood, Diet, High-Fat adverse effects, Energy Intake genetics, Gastrointestinal Transit physiology, Hypothermia prevention & control, Insulin blood, Leptin blood, Mice, Mice, Knockout, Mice, Transgenic, MicroRNAs, Mutation, Obesity drug therapy, Obesity genetics, Peripheral Nervous System drug effects, Peripheral Nervous System metabolism, Phenotype, Piperidines therapeutic use, Promoter Regions, Genetic, Pyrazoles therapeutic use, Receptor, Cannabinoid, CB1 genetics, Rimonabant, Triglycerides blood, Anti-Obesity Agents pharmacology, Body Weight drug effects, Central Nervous System metabolism, Energy Intake drug effects, Obesity metabolism, Piperidines pharmacology, Pyrazoles pharmacology, Receptor, Cannabinoid, CB1 metabolism
- Abstract
Cannabinoid receptor CB1 is expressed abundantly in the brain and presumably in the peripheral tissues responsible for energy metabolism. It is unclear if the antiobesity effects of rimonabant, a CB1 antagonist, are mediated through the central or the peripheral CB1 receptors. To address this question, we generated transgenic mice with central nervous system (CNS)-specific knockdown (KD) of CB1, by expressing an artificial microRNA (AMIR) under the control of the neuronal Thy1.2 promoter. In the mutant mice, CB1 expression was reduced in the brain and spinal cord, whereas no change was observed in the superior cervical ganglia (SCG), sympathetic trunk, enteric nervous system, and pancreatic ganglia. In contrast to the neuronal tissues, CB1 was undetectable in the brown adipose tissue (BAT) or the liver. Consistent with the selective loss of central CB1, agonist-induced hypothermia was attenuated in the mutant mice, but the agonist-induced delay of gastrointestinal transit (GIT), a primarily peripheral nervous system-mediated effect, was not. Compared to wild-type (WT) littermates, the mutant mice displayed reduced body weight (BW), adiposity, and feeding efficiency, and when fed a high-fat diet (HFD), showed decreased plasma insulin, leptin, cholesterol, and triglyceride levels, and elevated adiponectin levels. Furthermore, the therapeutic effects of rimonabant on food intake (FI), BW, and serum parameters were markedly reduced and correlated with the degree of CB1 KD. Thus, KD of CB1 in the CNS recapitulates the metabolic phenotype of CB1 knockout (KO) mice and diminishes rimonabant's efficacy, indicating that blockade of central CB1 is required for rimonabant's antiobesity actions.
- Published
- 2011
- Full Text
- View/download PDF
64. Effects of the beta3-adrenoceptor (Adrb3) agonist SR58611A (amibegron) on serotonergic and noradrenergic transmission in the rodent: relevance to its antidepressant/anxiolytic-like profile.
- Author
-
Claustre Y, Leonetti M, Santucci V, Bougault I, Desvignes C, Rouquier L, Aubin N, Keane P, Busch S, Chen Y, Palejwala V, Tocci M, Yamdagni P, Didier M, Avenet P, Le Fur G, Oury-Donat F, Scatton B, and Steinberg R
- Subjects
- Action Potentials drug effects, Action Potentials physiology, Adrenergic Uptake Inhibitors pharmacology, Adrenergic beta-2 Receptor Agonists, Analysis of Variance, Animals, Brain anatomy & histology, Brain cytology, Brain metabolism, Dose-Response Relationship, Drug, Drug Administration Routes, Drug Interactions, Fluoxetine pharmacology, Male, Mice, Microdialysis, Morpholines pharmacology, Motor Activity drug effects, Neurons drug effects, Neurons physiology, Rats, Reboxetine, Receptors, Adrenergic, beta-2 genetics, Receptors, Adrenergic, beta-2 metabolism, Selective Serotonin Reuptake Inhibitors pharmacology, Tryptophan metabolism, Adrenergic beta-Agonists pharmacology, Brain drug effects, Norepinephrine metabolism, Serotonin metabolism, Tetrahydronaphthalenes pharmacology
- Abstract
SR58611A is a selective beta(3)-adrenoceptor (Adrb3) agonist which has demonstrated antidepressant and anxiolytic properties in rodents. The present study confirmed the detection of Adrb3 mRNA transcript in rodent brain sub-regions and evaluated the effect of SR58611A on serotonergic and noradrenergic transmission in rats and mice in an attempt to elucidate the mechanism(s) underlying these properties. SR58611A (3 and 10 mg/kg, p.o.) increased the synthesis of 5-HT and tryptophan (Trp) levels in several rodent brain areas (cortex, hippocampus, hypothalamus, striatum). Moreover, SR58611A (10 mg/kg, p.o.) increased the release of 5-HT assessed by in vivo microdialysis in rat prefrontal cortex. Systemic (3 mg/kg, i.v.) or chronic administration of SR58611A (10 mg/kg, p.o.), in contrast to fluoxetine (15 mg/kg, p.o.), did not modify the activity of serotonergic neurons in the rat dorsal raphe nucleus. The increase in 5-HT synthesis induced by SR58611A was not observed in Adrb3s knockout mice, suggesting a selective involvement of Adrb3s in this effect. SR58611A (3 and 10 mg/kg, p.o.) did not modify norepinephrine synthesis and metabolism but increased its release in rat brain. Repeated administration of SR58611A (10 mg/kg, p.o.) did not modify basal norepinephrine release in rat prefrontal cortex whereas it prevented its tail-pinch stress-induced enhancement similarly to reboxetine (15 mg/kg, p.o.). Finally SR58611A increased the firing rate of noradrenergic neurons in the rat locus coeruleus following systemic (3 mg/kg, i.v.) or local (0.01 and 1 microM) but not chronic (10 mg/kg, p.o.) administration. These results suggest that the anxiolytic- and antidepressant-like activities of SR58611A involve an increase of brain serotonergic and noradrenergic neurotransmissions, triggered by activation of Adrb3s.
- Published
- 2008
- Full Text
- View/download PDF
65. Phage display of functional human TNF-alpha converting enzyme catalytic domain: a rapid method for the production of stabilized proteolytic proteins for assay development and high-throughput screening.
- Author
-
Chen Y, Diener K, Patel IR, Kawooya JK, Martin GA, Yamdagni P, Zhang X, Sandrasalphaa A, Sahasrabudhe S, and Busch SJ
- Subjects
- ADAM Proteins, ADAM17 Protein, Baculoviridae genetics, Catalytic Domain, Combinatorial Chemistry Techniques methods, Drug Evaluation, Preclinical methods, Enzyme Inhibitors pharmacology, Enzyme Stability, Escherichia coli genetics, Glutathione Transferase genetics, Glutathione Transferase metabolism, Humans, Metalloendopeptidases antagonists & inhibitors, Metalloendopeptidases genetics, Protein Engineering methods, Proteins genetics, Recombinant Proteins genetics, Recombinant Proteins metabolism, Biological Assay methods, Metalloendopeptidases metabolism, Peptide Library, Proteins metabolism
- Abstract
The catalytic domain of human tumor necrosis factor-alpha (TNF-alpha) converting enzyme (TACE) was expressed in a phage display system to determine whether stable and active enzyme could be made for high-throughput screening (HTS). This would address many issues around screening of proteases in this class. The phage-displayed TACE catalytic domain (PDT) properly cleaved the fusion protein of glutathione S-transferase (GST)-pro-TNF-alpha to generate the mature TNF-alpha in vitro. To determine the utility of the PDT in HTS, the authors further demonstrated that PDT was able to generate a strong reproducible fluorescence signal by cleaving a fluorogenic TNF-alpha-specific peptide in vitro. More important, the catalytic activity of the PDT was inhibited by a broad-spectrum matrix metalloprotease (MMP) inhibitor but not by an MMP-I specific inhibitor, illustrating the potential utility of PDT for HTS. The PDT was also compared with baculovirus-expressed TACE (BET) in these assays to establish the relative efficacy of PDT. Both PDT and BET showed a similar specific cleavage profile against the defined substrates. Activity of the BET, however, was stable at 4 degrees C for less than 24 h. In contrast, the PDT exhibited remarkable stability, losing very little activity even after 2 years at 4 degrees C. On the basis of these results, the authors concluded that the phage display system might be a useful tool for expressing proteins that have stability issues related to auto-proteolytic activity. Furthermore, the ease and low cost of large-scale production of phage should make it suitable for assay development and HTS.
- Published
- 2002
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.